GNPX•benzinga•
Genprex Announced It Has Entered Into An Exclusive Patent License Agreement With Uthealth Houston Granting Genprex Exclusivity And Commercial Rights Relating To Its Lead Drug Candidate, Reqorsa Gene Therapy (Quaratusugene Ozeplasmid) For The Potential Tre
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 6, 2025 by benzinga